Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic Adenocarcinoma
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: ERAS) | Delayed: 14.49 -0.13 (0.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.62 | 52 Week High | $ | |||
| Open | $14.82 | 52 Week Low | $ | |||
| Day High | $15.05 | P/E | N/A | |||
| Day Low | $14.38 | EPS | $ | |||
| Volume | 3,844,614 | |||||
